Literature DB >> 24262492

Cord blood banking activity in Iran National Cord Blood Bank: a two years experience.

Mostafa Jamali1, Kamran Atarodi1, Mozhdeh Nakhlestani1, Hasan Abolghasemi2, Hosein Sadegh3, Mohammad Faranoosh3, Khadije Golzade1, Razieh Fadai3, Fereshte Niknam1, Mahin Nikougoftar Zarif4.   

Abstract

Today umbilical cord blood (UCB) has known as a commonly used source of hematopoietic stem cells for allogeneic transplantation and many cord blood banks have been established around the world for collection and cryopreservation of cord blood units. Herein, we describe our experience at Iran National Cord Blood Bank (INCBB) during 2 years of activity. From November 2010 to 2012, UCBs were collected from 5 hospitals in Tehran. All the collection, processing, testing, cryopreservation and storage procedures were done according to standard operation procedures. Total nucleated cells (TNC) count, viability test, CD34+ cell count, colony forming unit (CFU) assay, screening tests and HLA typing were done on all banked units. Within 3770 collected units, only 32.9% fulfilled banking criteria. The mean volume of units was 105.2 ml and after volume reduction the mean of TNC, viability, CD34+ cells and CFUs was 10.76×10(8), 95.2%, 2.99×10(6) and 7.1×10(5), respectively. One unit was transplanted at Dec 2012 to a 5-year old patient with five of six HLA compatibilities. In our country banking of UCB is new and high rate of hematopoietic stem cell transplants needs expanding CB banks capacity to find more matching units, optimization of methods and sharing experiences to improve biological characterization of units.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Cord blood bank; Cord blood transplantation; Hematopoietic stem cells

Mesh:

Substances:

Year:  2013        PMID: 24262492     DOI: 10.1016/j.transci.2013.09.012

Source DB:  PubMed          Journal:  Transfus Apher Sci        ISSN: 1473-0502            Impact factor:   1.764


  4 in total

1.  Cord blood collection and banking from a population with highly diverse geographic origins increase HLA diversity in the registry and do not lower the proportion of validated cord blood units: experience of the Marseille Cord Blood Bank.

Authors:  C Bordoni; J Magalon; C Gilbertas; M Gamerre; P Le Coz; M Berthomieu; C Chabannon; J Di Cristofaro; C Picard
Journal:  Bone Marrow Transplant       Date:  2015-01-26       Impact factor: 5.483

2.  GFc7 as a Smart Growth Nanofactor for ex vivo Expansion and Cryoprotection of Humans' Hematopoietic Stem Cells.

Authors:  Amir Atashi; Mohammad Hassan Nazaran; Maryam Hafizi; Somayeh Kalanaky; Saideh Fakharzadeh; Ehsan Janzamin; Tarlan Arjmandi
Journal:  Int J Nanomedicine       Date:  2020-08-21

Review 3.  Umbilical Cord Blood Banking for Transplantation in Morocco: Problems and opportunities.

Authors:  Loubna Mazini; Nourredine Matar; Said Bouhya; Diaa Marzouk; Wagida Anwar; Meriem Khyatti
Journal:  J Stem Cells Regen Med       Date:  2014-11-28

Review 4.  Ethical challenges of cord blood banks: a scoping review.

Authors:  Madjid Soltani Gerdfaramarzi; Shabnam Bazmi; Mehrzad Kiani; Leila Afshar; Mohsen Fadavi; Seyed Ali Enjoo
Journal:  J Med Life       Date:  2022-06
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.